These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 21755815

  • 1. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients.
    Gupta R, Bhatia J, Gupta SK.
    Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815
    [Abstract] [Full Text] [Related]

  • 2. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR, Beukelman T, Onofrei A, Cassell S, Greenberg JD, Kavanaugh A, Reed G, Strand V, Kremer JM.
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [Abstract] [Full Text] [Related]

  • 3. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
    Sokolove J, Strand V, Greenberg JD, Curtis JR, Kavanaugh A, Kremer JM, Anofrei A, Reed G, Calabrese L, Hooper M, Baumgartner S, Furst DE, CORRONA Investigators.
    Ann Rheum Dis; 2010 Sep; 69(9):1612-7. PubMed ID: 20448284
    [Abstract] [Full Text] [Related]

  • 4. Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
    Genovese MC, Kremer JM, van Vollenhoven RF, Alten R, Scali JJ, Kelman A, Dimonaco S, Brockwell L.
    Arthritis Rheumatol; 2017 Sep; 69(9):1751-1761. PubMed ID: 28597609
    [Abstract] [Full Text] [Related]

  • 5. Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity.
    van Roon EN, Jansen TL, Houtman NM, Spoelstra P, Brouwers JR.
    Drug Saf; 2004 Sep; 27(5):345-52. PubMed ID: 15061688
    [Abstract] [Full Text] [Related]

  • 6. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
    Alves JA, Fialho SC, Morato EF, Castro GR, Zimmermann AF, Ribeiro GG, Neves FS, Pereira IA.
    Rev Bras Reumatol; 2011 Sep; 51(2):141-4. PubMed ID: 21584420
    [Abstract] [Full Text] [Related]

  • 7. Leflunomide-induced polymyositis in a patient with rheumatoid arthritis.
    Ochi S, Taniguchi K, Nagashima M.
    Mod Rheumatol; 2009 Sep; 19(4):443-6. PubMed ID: 19526307
    [Abstract] [Full Text] [Related]

  • 8. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis.
    Suissa S, Ernst P, Hudson M, Bitton A, Kezouh A.
    Am J Med; 2004 Jul 15; 117(2):87-92. PubMed ID: 15234643
    [Abstract] [Full Text] [Related]

  • 9. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.
    Alfaro-Lara R, Espinosa-Ortega HF, Arce-Salinas CA, PRECIS study group, all physicians belong to Division of Internal Medicine. Hospital Central Sur de Pemex.
    Reumatol Clin (Engl Ed); 2019 Jul 15; 15(3):133-139. PubMed ID: 28867467
    [Abstract] [Full Text] [Related]

  • 10. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C, Chen S, Gu Y, Lao Z, Ni L, Yu Q, Xu J, Li X, Liu J, Sun L, He P, Ma J, Xu S, Ding C.
    Chin Med J (Engl); 2003 Aug 15; 116(8):1228-34. PubMed ID: 12935395
    [Abstract] [Full Text] [Related]

  • 11. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Chen Z, Li XP, Li ZJ, Xu L, Li XM.
    Int Immunopharmacol; 2013 Mar 15; 15(3):474-7. PubMed ID: 23415907
    [Abstract] [Full Text] [Related]

  • 12. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
    Rajakulendran S, Gadsby K, Deighton C.
    Musculoskeletal Care; 2008 Dec 15; 6(4):233-45. PubMed ID: 18702106
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
    Mroczkowski PJ, Weinblatt ME, Kremer JM.
    Clin Exp Rheumatol; 1999 Dec 15; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
    Weinblatt ME, Kremer JM, Coblyn JS, Maier AL, Helfgott SM, Morrell M, Byrne VM, Kaymakcian MV, Strand V.
    Arthritis Rheum; 1999 Jul 15; 42(7):1322-8. PubMed ID: 10403258
    [Abstract] [Full Text] [Related]

  • 15. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM.
    Clin Ther; 1999 Nov 15; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [Abstract] [Full Text] [Related]

  • 16. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.
    Iannone F, La Montagna G, Bagnato G, Gremese E, Giardina A, Lapadula G.
    J Rheumatol; 2014 Feb 15; 41(2):286-92. PubMed ID: 24429167
    [Abstract] [Full Text] [Related]

  • 17. Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis.
    Mok MY, Ng WL, Yuen MF, Wong RW, Lau CS.
    Clin Exp Rheumatol; 2000 Feb 15; 18(3):363-8. PubMed ID: 10895374
    [Abstract] [Full Text] [Related]

  • 18. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.
    Rodriguez-Rodriguez L, Jover-Jover JA, Fontsere O, Peña-Blanco RC, León L, Fernández-Gutierrez B, Abásolo L.
    Scand J Rheumatol; 2013 Feb 15; 42(6):433-6. PubMed ID: 23742043
    [Abstract] [Full Text] [Related]

  • 19. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS, Park YW, Park JJ, Kang YM, Nam EJ, Kim SI, Lee JH, Yoo WH, Lee SI.
    Scand J Rheumatol; 2009 Feb 15; 38(1):11-4. PubMed ID: 19191187
    [Abstract] [Full Text] [Related]

  • 20. Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis.
    Bilasy SE, Essawy SS, Mandour MF, Ali EA, Zaitone SA.
    Pharmacol Rep; 2015 Feb 15; 67(1):102-14. PubMed ID: 25560583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.